RT Journal Article
SR Electronic
T1 Reducing long-term complications of type 2 diabetes
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 84
OP 87
VO 37
IS 11
YR 1999
UL http://dtb.bmj.com/content/37/11/84.abstract
AB Many patients with type 2 (late-onset; non-insulin-dependent) diabetes mellitus present with no symptoms, or become asymptomatic once treatment is started. Consequently, the condition is often regarded as trivial. In reality, the long-term outlook is poor, with 30% of patients developing one or more clinical complications within 10 years of diagnosis.1 Such complications include macrovascular disease (e.g. myocardial infarction, stroke), microvascular disease (e.g. retinopathy, nephropathy) and neuropathy. In this article, we examine the role of hypoglycaemic, antihypertensive and lipid-lowering drugs in preventing these complications.